Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats

European Journal of Pharmacology

Volumn 328, Issue 2-3, 1997, Pages 135-141

  Mandhane, Sanjay N ^a   Chopde, Chandrabhan T ^a   Ghosh, Anuradha K ^a  

^a RTM NAGPUR UNIVERSITY   (India)

Author keywords

Adenosine receptor agonist; Adenosine receptor antagonist; Catalepsy; Haloperidol; Theophylline

Indexed keywords

2 CHLOROADENOSINE; 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE 5' (N CYCLOPROPYLCARBOXAMIDE); ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; PHENYLISOPROPYLADENOSINE; SCOPOLAMINE; THEOPHYLLINE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 3,7-DIMETHYL-1-PROPARGYLXANTHINE; ADENOSINE; ADENOSINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; N (1 METHYL 2 PHENYLETHYL)ADENOSINE; N CYCLOPROPYL ADENOSINE 5' CARBOXAMIDE; N(6) CYCLOPENTYLADENOSINE; N(6)-CYCLOPENTYLADENOSINE; N-(1-METHYL-2-PHENYLETHYL)ADENOSINE; N-CYCLOPROPYL ADENOSINE-5'-CARBOXAMIDE; THEOBROMINE; XANTHINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG SELECTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

2-CHLOROADENOSINE; ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CATALEPSY; DOPAMINE ANTAGONISTS; HALOPERIDOL; MALE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SCOPOLAMINE; THEOBROMINE; THEOPHYLLINE; XANTHINES;

EID: 0030610127     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83039-7     Document Type: Article

References (44)

1. Ahtee L., Kaariainen I. The role of dopamine in pilocarpine-induced catalepsy. Naunyn-Schmiedeberg's Arch. Exp. Pathol. Pharmacol. 284:1974;25.
2. Barraco, R.A., 1991. Behavioral actions of adenosine and related substances. In: Phillis, J.W. (Ed.), Adenosine and Adenine Nucleotides as Regulators of Cellular Function. CRC Press, Boca Raton, p. 339.
3. Barraco R.A., Bryant S.D. Depression of locomotor activity following bilateral injections of adenosine analogs into the striatum of mice. Med. Sci. Res. 15:1987;421.
4. 2A receptors in the nucleus accumbens mediate locomotor depression. Brain Res. Bull. 31:1993;397.
5. Bowers M.B., Roth R.H. Interaction of atropine-like drugs with dopamine-containing neurons in rat brain. Br. J. Pharmacol. 44:1972;301.
6. 2A purine receptors regulate striatal acetylcholine release. J. Neurochem. 55:1990;31.
7. 1 selective antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 335:1987;59.
8. Casas M., Ferre S., Guix T., Jane F. Theophylline reverses haloperidol-induced catalepsy in the rat: possible relevance to the pharmacological treatment of psychosis. Biol. Psychiatry. 24:1988;642.
9. Daly J.W. Adenosine receptors: targets for future drugs. J. Med. Chem. 25:1982;197.
10. 2 adenosine receptor regulating coronary blood flow. Biochem. Pharmacol. 35:1986;2467.
11. Dijk S., Krugers H.J., Korf J. The effect of theophylline and immobilization stress on haloperidol-induced catalepsy and on metabolism in the striatum and hippocampus, studied with lactography. Neuropharmacology. 30:1991;469.
12. 2 receptor involvement in the hypomobility effects of adenosine analogues in mice. Eur. J. Pharmacol. 168:1989;285.
13. Ferre S., Herrera-Marschitz M., Grabowska-Anden M., Casas M., Ungerstedt U., Anden N.E. Postsynaptic dopamine/adenosine interaction. II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice Eur. J. Pharmacol. 192:1991;31.
14. 2 receptors induces catalepsy. Neurosci. Lett. 130:1991;162.
15. 2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. USA. 88:1991;7238.
16. 2 dopamine receptors in rat striatum. Mol. Brain Res. 14:1992;186.
17. Forloni G., Fisone G., Consolo S., Ladinsky H. Qualitative differences in the effects of adenosine analogs on the cholinergic systems of rat striatum and hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 334:1986;85.
18. Fuxe K., Ungerstedt U. Action of caffeine and theophylline on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with dopa and dopamine receptor agonist. Med. Biol. 52:1974;48.
19. Hertting G., Zumstein A., Jackisch R., Hoffman I., Starke K. Modulation by endogenous dopamine of release of acetylcholine in the caudate nucleus of the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 315:1989;111.
20. Hornykiewicz O. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). Br. Med. Bull. 29:1973;172.
21. 1 receptor in vivo. Acta Physiol. Scand. 125:1985;341.
22. Jacobson K.A., VanGalen P.J.M., Williams M. Adenosine receptors: pharmacology, structure-activity relationship and therapeutic potential. J. Med. Chem. 35:1992;407.
23. Jain N., Kemp N., Adeyemo O., Buchanan P., Stone T.W. Anxiolytic activity of adenosine receptor activation in mice. Br. J. Pharmacol. 116:1995;2127.
24. 3H]-CGS 21680 binding sites in the rat striatum: copurification with cholinergic nerve terminals. Neurochem. Int. 23:1993;115.
25. 2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther. 267:1993;801.
26. 2A receptor antagonist with anticataleptic activity. Eur. J. Pharmacol. 256:1994;263.
27. Kulkarni S.K., Arzi A., Kaul P.N. Modifications of drug induced catatonia and tremors by quipazine in rats and mice. Jpn. J. Pharmacol. 30:1980;129.
28. 2A receptor-mediated modulation of striatal acetylcholine release in vivo. J. Neurochem. 66:1996;1882.
29. 1 adenosine receptor from rat brain. Mol. Pharmacol. 40:1991;1.
30. Mally J., Stone T.W. The effect of theophylline on parkinsonian symptoms. J. Pharm. Pharmacol. 46:1994;515.
31. 1 receptors. Brain Res. Bull. 27:1991;101.
32. 2 dopamine receptors in neuroleptic catalepsy. Eur. J. Pharmacol. 182:1990;327.
33. Palmer T.M., Stiles G.L. Review: Neurotransmitter receptors. VII: Adenosine receptors Neuropharmacology. 34:1995;683.
34. Paxinos, G., Watson, C., 1985. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
35. 2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience. 68:1995;721.
36. 1-adenosine receptor that is widely expressed in brain and spinal cord. Mol. Endocrinol. 5:1991;1037.
37. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons. An in situ hybridization histochemistry study. J. Neurochem. 57:1991;1062.
38. Sethy V.H., Van Woert M.H. Regulation of striatal acetylcholine concentration by dopamine receptors. Nature. 251:1974;529.
39. Siegel, S., 1956. Nonparametric Statistics for the Behavioural Sciences. McGraw-Hill Kogakusha, Tokyo.
40. Snyder D.H., Katims J.J., Annau Z., Bruns R.F., Daly J.W. Adenosine receptors and behavioural actions of methylxanthines. Proc. Natl. Acad. Sci. USA. 78:1981;3260.
41. 2 adenosine receptors. Life Sci. 39:1986;743.
42. 2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation. Psychopharmacology. 111:1993;383.
43. Williams M. Purine receptors in mammalian tissues: pharmacology and functional significance. Annu. Rev. Pharmacol. Toxicol. 27:1987;315.
44. Zarrindast M.R., Modabber M., Sabetkasai M. Influences of different adenosine receptor subtypes on catalepsy in mice. Psychopharmacology. 113:1993;257.